

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine metabolic process (GO:0006558) | 6.26651976 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.26651976 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.22162526 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.22162526 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 6.21981271 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.99324502 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.72636674 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.47515014 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.37167488 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.37167488 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.37167488 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.33927373 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 5.29692241 |
| 14 | urea cycle (GO:0000050) | 5.10817336 |
| 15 | urea metabolic process (GO:0019627) | 5.10817336 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.08799601 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.01736935 |
| 18 | lysine metabolic process (GO:0006553) | 5.00284119 |
| 19 | lysine catabolic process (GO:0006554) | 5.00284119 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95906035 |
| 21 | cysteine metabolic process (GO:0006534) | 4.95587485 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.94928602 |
| 23 | bile acid biosynthetic process (GO:0006699) | 4.84340156 |
| 24 | regulation of cholesterol esterification (GO:0010872) | 4.81844103 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.79996842 |
| 26 | negative regulation of cholesterol transport (GO:0032375) | 4.74427544 |
| 27 | negative regulation of sterol transport (GO:0032372) | 4.74427544 |
| 28 | phospholipid efflux (GO:0033700) | 4.70712512 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.69618150 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.64497346 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.64312892 |
| 32 | drug catabolic process (GO:0042737) | 4.64127617 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.50874781 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 4.40846889 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.40649491 |
| 36 | bile acid metabolic process (GO:0008206) | 4.37998072 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 4.37226064 |
| 38 | flavonoid metabolic process (GO:0009812) | 4.34637821 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.32798314 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.32798314 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.32798314 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.28785080 |
| 43 | protein carboxylation (GO:0018214) | 4.28785080 |
| 44 | bile acid and bile salt transport (GO:0015721) | 4.27554840 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.26110025 |
| 46 | intestinal cholesterol absorption (GO:0030299) | 4.23823299 |
| 47 | regulation of protein activation cascade (GO:2000257) | 4.20957492 |
| 48 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.20187592 |
| 49 | complement activation, alternative pathway (GO:0006957) | 4.16429163 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.14188397 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.14188397 |
| 52 | drug transmembrane transport (GO:0006855) | 4.09995671 |
| 53 | regulation of fibrinolysis (GO:0051917) | 4.06583029 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.06400780 |
| 55 | cholesterol efflux (GO:0033344) | 4.04970573 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.03270379 |
| 57 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.03270379 |
| 58 | plasma lipoprotein particle assembly (GO:0034377) | 4.03112027 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 4.02232740 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.01460742 |
| 61 | ethanol metabolic process (GO:0006067) | 3.98816396 |
| 62 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.95639178 |
| 63 | regulation of complement activation (GO:0030449) | 3.95016602 |
| 64 | NADH metabolic process (GO:0006734) | 3.89188560 |
| 65 | cellular glucuronidation (GO:0052695) | 3.89152415 |
| 66 | omega-hydroxylase P450 pathway (GO:0097267) | 3.89124777 |
| 67 | regulation of bile acid biosynthetic process (GO:0070857) | 3.87607899 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.86164128 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.84998397 |
| 70 | ethanol oxidation (GO:0006069) | 3.84547249 |
| 71 | intestinal absorption (GO:0050892) | 3.83528951 |
| 72 | short-chain fatty acid metabolic process (GO:0046459) | 3.82287470 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.81882874 |
| 74 | exogenous drug catabolic process (GO:0042738) | 3.81183945 |
| 75 | urate metabolic process (GO:0046415) | 3.80646708 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.79174655 |
| 77 | cholesterol homeostasis (GO:0042632) | 3.77312527 |
| 78 | ketone body metabolic process (GO:1902224) | 3.77121300 |
| 79 | fatty acid beta-oxidation (GO:0006635) | 3.73229480 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72770324 |
| 81 | sterol homeostasis (GO:0055092) | 3.72209276 |
| 82 | glycine metabolic process (GO:0006544) | 3.71770477 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 3.71555050 |
| 84 | phospholipid homeostasis (GO:0055091) | 3.71282841 |
| 85 | protein-lipid complex assembly (GO:0065005) | 3.70066717 |
| 86 | lipoprotein metabolic process (GO:0042157) | 3.69172473 |
| 87 | arginine metabolic process (GO:0006525) | 3.67595040 |
| 88 | fatty acid oxidation (GO:0019395) | 3.66350484 |
| 89 | tyrosine metabolic process (GO:0006570) | 3.65998666 |
| 90 | drug transport (GO:0015893) | 3.65164095 |
| 91 | glutamate metabolic process (GO:0006536) | 3.64818218 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 3.64281876 |
| 93 | drug metabolic process (GO:0017144) | 3.63731458 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.63321527 |
| 95 | amine catabolic process (GO:0009310) | 3.63321527 |
| 96 | phenylpropanoid metabolic process (GO:0009698) | 3.62308473 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59416461 |
| 98 | lipid oxidation (GO:0034440) | 3.58744748 |
| 99 | oxidative demethylation (GO:0070989) | 3.57069167 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.57016025 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.56045126 |
| 102 | heme transport (GO:0015886) | 3.54976694 |
| 103 | organic acid catabolic process (GO:0016054) | 3.54186784 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.54186784 |
| 105 | angiotensin maturation (GO:0002003) | 3.53398196 |
| 106 | carnitine metabolic process (GO:0009437) | 3.53291839 |
| 107 | fatty acid catabolic process (GO:0009062) | 3.50944933 |
| 108 | diacylglycerol metabolic process (GO:0046339) | 3.50489857 |
| 109 | lipoprotein transport (GO:0042953) | 3.49080742 |
| 110 | glucuronate metabolic process (GO:0019585) | 3.48425758 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.48425758 |
| 112 | monocarboxylic acid catabolic process (GO:0072329) | 3.47378811 |
| 113 | proline metabolic process (GO:0006560) | 3.47199752 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 3.40553215 |
| 115 | alkaloid metabolic process (GO:0009820) | 3.38401946 |
| 116 | protein-lipid complex subunit organization (GO:0071825) | 3.34451124 |
| 117 | nucleobase catabolic process (GO:0046113) | 3.27337078 |
| 118 | regulation of cholesterol metabolic process (GO:0090181) | 3.22294419 |
| 119 | hormone catabolic process (GO:0042447) | 3.18883634 |
| 120 | fructose metabolic process (GO:0006000) | 3.18037642 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.16257725 |
| 122 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.14343651 |
| 123 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.09339271 |
| 124 | blood coagulation, intrinsic pathway (GO:0007597) | 3.06017152 |
| 125 | neurotransmitter catabolic process (GO:0042135) | 2.99539377 |
| 126 | regulation of guanylate cyclase activity (GO:0031282) | 2.94594970 |
| 127 | arginine catabolic process (GO:0006527) | 2.94149853 |
| 128 | complement activation, classical pathway (GO:0006958) | 2.91015941 |
| 129 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.89236018 |
| 130 | protein activation cascade (GO:0072376) | 2.89036158 |
| 131 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.83974933 |
| 132 | oxaloacetate metabolic process (GO:0006107) | 2.81416394 |
| 133 | sodium ion homeostasis (GO:0055078) | 2.77581080 |
| 134 | complement activation (GO:0006956) | 2.66389423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.73148695 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.97567768 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.33287106 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.33326475 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.12553710 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.09505033 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.23829898 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.16578222 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.14322609 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.08476523 |
| 11 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.42496047 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.38479672 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.32504184 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27886342 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95823327 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90058714 |
| 17 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.83165942 |
| 18 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.77426433 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76718586 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.75446140 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71146418 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66113691 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65788006 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.55273792 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52247931 |
| 26 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45679873 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44810869 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.44611866 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41383897 |
| 30 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41040579 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38239770 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38185032 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37563129 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.36621559 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34972590 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34365481 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34065789 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33632480 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32866148 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32764134 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32701757 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30672562 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28583307 |
| 44 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.26607248 |
| 45 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.26250707 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24513027 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22735160 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18451376 |
| 49 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17483287 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17383621 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17257078 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16513290 |
| 53 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12462857 |
| 54 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12415707 |
| 55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.10284277 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09783292 |
| 57 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.09312634 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08668464 |
| 59 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.07982909 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07241613 |
| 61 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.06950040 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06848006 |
| 63 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06402027 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04784158 |
| 65 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04669138 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.03327273 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02595815 |
| 68 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.01389743 |
| 69 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.01013370 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97681222 |
| 71 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97011591 |
| 72 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.96994885 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94645848 |
| 74 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.94619026 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93911477 |
| 76 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93004097 |
| 77 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.92287992 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91412264 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91281016 |
| 80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91211384 |
| 81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.91034189 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90739434 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90184673 |
| 84 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89321452 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89155242 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88818872 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88795552 |
| 88 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.88181181 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87254995 |
| 90 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86928399 |
| 91 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.86336282 |
| 92 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86144338 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86029455 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85572113 |
| 95 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85417114 |
| 96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85347965 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84724350 |
| 98 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.84480060 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83994664 |
| 100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83493954 |
| 101 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83182820 |
| 102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82894682 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 0.82624605 |
| 104 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.81641455 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80802896 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80452394 |
| 107 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79155832 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78448099 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78173096 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78041693 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77690013 |
| 112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.77292117 |
| 113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77255552 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76397769 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76324440 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75474323 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75441251 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74881554 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74697196 |
| 120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74576010 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.72000920 |
| 122 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.71940144 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71737558 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71581341 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71496626 |
| 126 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.70852687 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.70790728 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70664771 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70186325 |
| 130 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.68590413 |
| 131 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68497910 |
| 132 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67730217 |
| 133 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67275984 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.66684260 |
| 135 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.66025823 |
| 136 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.65347056 |
| 137 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64218678 |
| 138 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.63775087 |
| 139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62630550 |
| 140 | SA1_27219007_Chip-Seq_Bcells_Human | 0.62401745 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62358947 |
| 142 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.61155073 |
| 143 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.60812068 |
| 144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.60793621 |
| 145 | P300_27268052_Chip-Seq_Bcells_Human | 0.60700098 |
| 146 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.60065931 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59269805 |
| 148 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.58709174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.67315064 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.41124665 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.59681549 |
| 4 | MP0005365_abnormal_bile_salt | 5.38741066 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.68212382 |
| 6 | MP0009840_abnormal_foam_cell | 3.90562419 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.62183746 |
| 8 | MP0003252_abnormal_bile_duct | 3.61561866 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.33417120 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.17524921 |
| 11 | MP0005332_abnormal_amino_acid | 2.84539191 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.77747450 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.63792115 |
| 14 | MP0005083_abnormal_biliary_tract | 2.50859936 |
| 15 | MP0003122_maternal_imprinting | 2.16620071 |
| 16 | MP0003195_calcinosis | 2.14732412 |
| 17 | MP0003879_abnormal_hair_cell | 2.13667072 |
| 18 | MP0000609_abnormal_liver_physiology | 2.07020782 |
| 19 | MP0004147_increased_porphyrin_level | 2.05426568 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.95685550 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.91354902 |
| 22 | MP0005423_abnormal_somatic_nervous | 1.89325500 |
| 23 | MP0003329_amyloid_beta_deposits | 1.86722484 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.84500709 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.80660138 |
| 26 | MP0004270_analgesia | 1.69911808 |
| 27 | MP0001764_abnormal_homeostasis | 1.62865801 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.50993998 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47623801 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.39827524 |
| 31 | MP0000566_synostosis | 1.38265617 |
| 32 | MP0003868_abnormal_feces_composition | 1.36203940 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.36040218 |
| 34 | MP0005636_abnormal_mineral_homeostasis | 1.25432274 |
| 35 | MP0001664_abnormal_digestion | 1.24492751 |
| 36 | MP0003011_delayed_dark_adaptation | 1.23384794 |
| 37 | MP0005451_abnormal_body_composition | 1.22266339 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.17211494 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.16535837 |
| 40 | MP0004859_abnormal_synaptic_plasticity | 1.13120106 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.12762027 |
| 42 | MP0002132_abnormal_respiratory_system | 1.12413662 |
| 43 | MP0000598_abnormal_liver_morphology | 1.12325978 |
| 44 | MP0003186_abnormal_redox_activity | 1.09478059 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.08506016 |
| 46 | MP0001756_abnormal_urination | 1.07785119 |
| 47 | MP0005670_abnormal_white_adipose | 1.07219032 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.06228435 |
| 49 | MP0008872_abnormal_physiological_respon | 1.06187193 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.06024318 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.04944592 |
| 52 | MP0003123_paternal_imprinting | 1.02622202 |
| 53 | MP0003880_abnormal_central_pattern | 1.00080888 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 0.99599308 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 0.98383922 |
| 56 | MP0008469_abnormal_protein_level | 0.95845389 |
| 57 | MP0009642_abnormal_blood_homeostasis | 0.94387680 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 0.93771889 |
| 59 | MP0004043_abnormal_pH_regulation | 0.93511856 |
| 60 | MP0002136_abnormal_kidney_physiology | 0.91621126 |
| 61 | MP0009764_decreased_sensitivity_to | 0.91257923 |
| 62 | MP0009697_abnormal_copulation | 0.90524315 |
| 63 | MP0002653_abnormal_ependyma_morphology | 0.90201731 |
| 64 | MP0002822_catalepsy | 0.89827395 |
| 65 | MP0000604_amyloidosis | 0.87655442 |
| 66 | MP0000678_abnormal_parathyroid_gland | 0.82976819 |
| 67 | MP0001529_abnormal_vocalization | 0.81697224 |
| 68 | MP0002557_abnormal_social/conspecific_i | 0.81694912 |
| 69 | MP0002249_abnormal_larynx_morphology | 0.81085420 |
| 70 | MP0004130_abnormal_muscle_cell | 0.77121657 |
| 71 | MP0002064_seizures | 0.76716907 |
| 72 | MP0009763_increased_sensitivity_to | 0.76554924 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.76481230 |
| 74 | MP0003787_abnormal_imprinting | 0.74911689 |
| 75 | MP0004858_abnormal_nervous_system | 0.74683767 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.74257871 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.73404760 |
| 78 | MP0000013_abnormal_adipose_tissue | 0.72882666 |
| 79 | MP0001984_abnormal_olfaction | 0.72809604 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.72552146 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 0.72316729 |
| 82 | MP0003300_gastrointestinal_ulcer | 0.70538416 |
| 83 | MP0000538_abnormal_urinary_bladder | 0.70051238 |
| 84 | MP0005266_abnormal_metabolism | 0.69802468 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.68144901 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.67946769 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.67745794 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.67604433 |
| 89 | MP0003878_abnormal_ear_physiology | 0.67388562 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.67388562 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.67369787 |
| 92 | MP0002971_abnormal_brown_adipose | 0.67133675 |
| 93 | MP0002638_abnormal_pupillary_reflex | 0.67131563 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.66810301 |
| 95 | MP0002063_abnormal_learning/memory/cond | 0.66591170 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.66161923 |
| 97 | MP0002272_abnormal_nervous_system | 0.65345210 |
| 98 | MP0009745_abnormal_behavioral_response | 0.64422521 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.64357776 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.64354652 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.64335073 |
| 102 | MP0003436_decreased_susceptibility_to | 0.62782364 |
| 103 | MP0005448_abnormal_energy_balance | 0.62683572 |
| 104 | MP0001663_abnormal_digestive_system | 0.62464097 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 0.62236889 |
| 106 | MP0002254_reproductive_system_inflammat | 0.61665260 |
| 107 | MP0005334_abnormal_fat_pad | 0.61264757 |
| 108 | MP0003121_genomic_imprinting | 0.60756961 |
| 109 | MP0003690_abnormal_glial_cell | 0.60599708 |
| 110 | MP0001873_stomach_inflammation | 0.60598207 |
| 111 | MP0005499_abnormal_olfactory_system | 0.59498464 |
| 112 | MP0005394_taste/olfaction_phenotype | 0.59498464 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.59156693 |
| 114 | MP0004924_abnormal_behavior | 0.59156693 |
| 115 | MP0005166_decreased_susceptibility_to | 0.58186007 |
| 116 | MP0004133_heterotaxia | 0.57919132 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.57062500 |
| 118 | MP0001486_abnormal_startle_reflex | 0.56288795 |
| 119 | MP0005647_abnormal_sex_gland | 0.55828318 |
| 120 | MP0010155_abnormal_intestine_physiology | 0.55555345 |
| 121 | MP0002102_abnormal_ear_morphology | 0.55480132 |
| 122 | MP0004142_abnormal_muscle_tone | 0.55474253 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.55213658 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.55037035 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.54844116 |
| 126 | MP0002229_neurodegeneration | 0.53419798 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.53412083 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.52314800 |
| 129 | MP0001661_extended_life_span | 0.51832913 |
| 130 | MP0008873_increased_physiological_sensi | 0.51227352 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.51127440 |
| 132 | MP0005535_abnormal_body_temperature | 0.50380485 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.49158215 |
| 134 | MP0000462_abnormal_digestive_system | 0.49072937 |
| 135 | MP0009053_abnormal_anal_canal | 0.47858569 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.47484179 |
| 137 | MP0003953_abnormal_hormone_level | 0.46946598 |
| 138 | MP0002135_abnormal_kidney_morphology | 0.46184089 |
| 139 | MP0003283_abnormal_digestive_organ | 0.44455600 |
| 140 | MP0005408_hypopigmentation | 0.44451775 |
| 141 | MP0003075_altered_response_to | 0.43745196 |
| 142 | MP0003866_abnormal_defecation | 0.42886472 |
| 143 | MP0002269_muscular_atrophy | 0.38969341 |
| 144 | MP0004947_skin_inflammation | 0.37411693 |
| 145 | MP0002876_abnormal_thyroid_physiology | 0.37125105 |
| 146 | MP0009115_abnormal_fat_cell | 0.37096814 |
| 147 | MP0005395_other_phenotype | 0.36192555 |
| 148 | MP0001849_ear_inflammation | 0.35711204 |
| 149 | MP0002796_impaired_skin_barrier | 0.35237558 |
| 150 | MP0000249_abnormal_blood_vessel | 0.34969295 |
| 151 | MP0005330_cardiomyopathy | 0.34582549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.02371419 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.80170055 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.75740926 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.57818112 |
| 5 | Xanthomatosis (HP:0000991) | 5.55132997 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.49394712 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.83924605 |
| 8 | Hyperglycinuria (HP:0003108) | 4.50516137 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.43725130 |
| 10 | Hyperammonemia (HP:0001987) | 4.42848473 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.22070515 |
| 12 | Complement deficiency (HP:0004431) | 4.18905092 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.17640737 |
| 14 | Hemorrhage of the eye (HP:0011885) | 4.08987234 |
| 15 | Ketosis (HP:0001946) | 4.05563343 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.98090434 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 3.98090434 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.93136277 |
| 19 | Hyperglycinemia (HP:0002154) | 3.80950255 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.79615100 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.74469159 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.73341271 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.65868300 |
| 24 | Fat malabsorption (HP:0002630) | 3.62579076 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.56882543 |
| 26 | Joint hemorrhage (HP:0005261) | 3.53352377 |
| 27 | Gout (HP:0001997) | 3.48310475 |
| 28 | Ketoacidosis (HP:0001993) | 3.44948729 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.42470779 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.41505285 |
| 31 | Epidermoid cyst (HP:0200040) | 3.37622298 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37615250 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.33138522 |
| 34 | Abnormality of purine metabolism (HP:0004352) | 3.29172189 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.25863016 |
| 36 | Malnutrition (HP:0004395) | 3.25201910 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.19244670 |
| 38 | Abnormality of complement system (HP:0005339) | 3.16953586 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 3.05161927 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.05161927 |
| 41 | Cerebral palsy (HP:0100021) | 3.04365479 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 2.99044235 |
| 43 | Abnormality of methionine metabolism (HP:0010901) | 2.95576636 |
| 44 | Hyperbilirubinemia (HP:0002904) | 2.91731790 |
| 45 | Metabolic acidosis (HP:0001942) | 2.88705194 |
| 46 | Polyphagia (HP:0002591) | 2.86802177 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.86065904 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.76996675 |
| 49 | Late onset (HP:0003584) | 2.73948568 |
| 50 | Widely patent fontanelles and sutures (HP:0004492) | 2.71291966 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.71238723 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.71238723 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.65274041 |
| 54 | Lethargy (HP:0001254) | 2.60596812 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.54798221 |
| 56 | Skin nodule (HP:0200036) | 2.51769263 |
| 57 | Increased purine levels (HP:0004368) | 2.51033616 |
| 58 | Hyperuricemia (HP:0002149) | 2.51033616 |
| 59 | Sensorimotor neuropathy (HP:0007141) | 2.47562581 |
| 60 | Vascular calcification (HP:0004934) | 2.46945815 |
| 61 | Decreased circulating renin level (HP:0003351) | 2.42983577 |
| 62 | Myocardial infarction (HP:0001658) | 2.42817709 |
| 63 | Abnormality of serum amino acid levels (HP:0003112) | 2.42245399 |
| 64 | Glomerulonephritis (HP:0000099) | 2.39913848 |
| 65 | Irritability (HP:0000737) | 2.38355278 |
| 66 | Acanthocytosis (HP:0001927) | 2.37583679 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 2.37540024 |
| 68 | Ankle clonus (HP:0011448) | 2.35123176 |
| 69 | Steatorrhea (HP:0002570) | 2.33355141 |
| 70 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.32736297 |
| 71 | Growth hormone excess (HP:0000845) | 2.31401581 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.28416329 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.28287005 |
| 74 | Cholecystitis (HP:0001082) | 2.28287005 |
| 75 | Retinal atrophy (HP:0001105) | 2.28191422 |
| 76 | Alkalosis (HP:0001948) | 2.25541604 |
| 77 | Abnormal cartilage morphology (HP:0002763) | 2.25378380 |
| 78 | Abnormality of urine glucose concentration (HP:0011016) | 2.24980514 |
| 79 | Glycosuria (HP:0003076) | 2.24980514 |
| 80 | Esophageal varix (HP:0002040) | 2.24741922 |
| 81 | Spastic diplegia (HP:0001264) | 2.24301880 |
| 82 | Hyperactive renin-angiotensin system (HP:0000841) | 2.23812806 |
| 83 | Vomiting (HP:0002013) | 2.22189112 |
| 84 | Pigmentary retinal degeneration (HP:0001146) | 2.22130237 |
| 85 | Abnormality of vitamin B metabolism (HP:0004340) | 2.20429780 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.18396747 |
| 87 | Confusion (HP:0001289) | 2.16974226 |
| 88 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15375890 |
| 89 | Cerebral edema (HP:0002181) | 2.13437207 |
| 90 | Cholelithiasis (HP:0001081) | 2.11214379 |
| 91 | Ileus (HP:0002595) | 2.11125809 |
| 92 | Pancreatitis (HP:0001733) | 2.10401337 |
| 93 | Hyperphosphaturia (HP:0003109) | 2.10291524 |
| 94 | Spontaneous abortion (HP:0005268) | 2.09905878 |
| 95 | Neonatal onset (HP:0003623) | 2.08265371 |
| 96 | Metabolic alkalosis (HP:0200114) | 2.06975957 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05845545 |
| 98 | Abnormal gallbladder morphology (HP:0012437) | 2.05124698 |
| 99 | Nausea (HP:0002018) | 2.05112802 |
| 100 | Abnormality of renin-angiotensin system (HP:0000847) | 2.04576742 |
| 101 | Potter facies (HP:0002009) | 2.04552699 |
| 102 | Facial shape deformation (HP:0011334) | 2.04552699 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 2.03983575 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.03851608 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 2.03464624 |
| 106 | Nephrolithiasis (HP:0000787) | 2.01844390 |
| 107 | Enlarged kidneys (HP:0000105) | 1.99758375 |
| 108 | Amyloidosis (HP:0011034) | 1.97991731 |
| 109 | Abnormality of vitamin metabolism (HP:0100508) | 1.95359984 |
| 110 | Abnormal urine phosphate concentration (HP:0012599) | 1.93028042 |
| 111 | Brushfield spots (HP:0001088) | 1.89104043 |
| 112 | Abnormal eating behavior (HP:0100738) | 1.87672262 |
| 113 | Poikilocytosis (HP:0004447) | 1.86925486 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 1.85138761 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84912649 |
| 116 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84776252 |
| 117 | Polycythemia (HP:0001901) | 1.84721144 |
| 118 | Increased serum pyruvate (HP:0003542) | 1.83622188 |
| 119 | Rhabdomyolysis (HP:0003201) | 1.82675570 |
| 120 | Nephritis (HP:0000123) | 1.82218523 |
| 121 | Myoglobinuria (HP:0002913) | 1.82157596 |
| 122 | Abnormality of the vitreous humor (HP:0004327) | 1.80386713 |
| 123 | Axonal loss (HP:0003447) | 1.79738840 |
| 124 | Hypophosphatemia (HP:0002148) | 1.79575752 |
| 125 | Wide cranial sutures (HP:0010537) | 1.77833134 |
| 126 | Rickets (HP:0002748) | 1.75380773 |
| 127 | Chronic diarrhea (HP:0002028) | 1.72396630 |
| 128 | Abdominal distention (HP:0003270) | 1.71850931 |
| 129 | Reticulocytosis (HP:0001923) | 1.70169200 |
| 130 | Joint swelling (HP:0001386) | 1.66311037 |
| 131 | Abnormal tarsal ossification (HP:0008369) | 1.65203371 |
| 132 | Abnormality of glycolysis (HP:0004366) | 1.63951104 |
| 133 | Myopathic facies (HP:0002058) | 1.63548228 |
| 134 | Elevated alkaline phosphatase (HP:0003155) | 1.62026348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.01395137 |
| 2 | ERN1 | 4.05212352 |
| 3 | MST1R | 3.88251856 |
| 4 | TRIB3 | 3.43204351 |
| 5 | PKN2 | 3.27979387 |
| 6 | FGFR4 | 3.12008180 |
| 7 | SIK1 | 2.46763691 |
| 8 | MARK1 | 2.30997944 |
| 9 | MAP3K10 | 2.25658091 |
| 10 | EPHA4 | 2.24470477 |
| 11 | SIK2 | 2.20931898 |
| 12 | TAOK3 | 2.15367212 |
| 13 | FLT3 | 2.01352966 |
| 14 | MAP3K11 | 1.86706188 |
| 15 | PTK6 | 1.86526253 |
| 16 | NEK1 | 1.75935661 |
| 17 | MAP2K2 | 1.68988271 |
| 18 | CASK | 1.64272153 |
| 19 | GRK6 | 1.61789887 |
| 20 | PIK3CA | 1.61029358 |
| 21 | LMTK2 | 1.55127016 |
| 22 | INSRR | 1.54011837 |
| 23 | MAP4K2 | 1.49250593 |
| 24 | PHKG1 | 1.48558994 |
| 25 | PHKG2 | 1.48558994 |
| 26 | MAPK11 | 1.44463851 |
| 27 | RIPK1 | 1.43319519 |
| 28 | TYK2 | 1.41608689 |
| 29 | FRK | 1.39409494 |
| 30 | PRKG2 | 1.37763517 |
| 31 | KSR2 | 1.36754009 |
| 32 | TBK1 | 1.36274199 |
| 33 | TYRO3 | 1.23974841 |
| 34 | MYLK | 1.23884877 |
| 35 | TXK | 1.23865249 |
| 36 | NTRK3 | 1.20461706 |
| 37 | EPHA3 | 1.20413166 |
| 38 | PIK3CG | 1.13251017 |
| 39 | DYRK2 | 1.12421449 |
| 40 | KDR | 1.11904748 |
| 41 | NME1 | 1.10286557 |
| 42 | TGFBR2 | 1.09361708 |
| 43 | ERBB2 | 1.09119244 |
| 44 | MAP2K7 | 1.08555982 |
| 45 | TESK1 | 1.07251429 |
| 46 | NTRK2 | 1.07009644 |
| 47 | WNK3 | 1.06946548 |
| 48 | MAP2K3 | 1.06500585 |
| 49 | MAP3K3 | 1.04556373 |
| 50 | DYRK1B | 1.04474017 |
| 51 | WNK4 | 1.03316185 |
| 52 | IRAK3 | 1.02912305 |
| 53 | EPHB1 | 1.02679478 |
| 54 | MET | 1.02256095 |
| 55 | ERBB4 | 1.01852589 |
| 56 | MAP3K7 | 1.00661590 |
| 57 | TIE1 | 0.99634784 |
| 58 | MAP3K4 | 0.98818802 |
| 59 | PRKD3 | 0.97296839 |
| 60 | EPHA2 | 0.96915827 |
| 61 | MAPK13 | 0.95135026 |
| 62 | ACVR1B | 0.94210401 |
| 63 | MAP4K1 | 0.93611004 |
| 64 | JAK2 | 0.93234606 |
| 65 | ABL2 | 0.93092102 |
| 66 | PRKAA2 | 0.92433898 |
| 67 | FGFR3 | 0.90918218 |
| 68 | MAP2K1 | 0.90243955 |
| 69 | EPHB2 | 0.88190587 |
| 70 | ICK | 0.86833716 |
| 71 | LRRK2 | 0.85459841 |
| 72 | MAP3K2 | 0.84618963 |
| 73 | BCR | 0.84017604 |
| 74 | RET | 0.83989566 |
| 75 | PAK4 | 0.83515257 |
| 76 | CAMKK1 | 0.82848479 |
| 77 | EEF2K | 0.82743610 |
| 78 | CAMK1D | 0.79815609 |
| 79 | CDK19 | 0.79690078 |
| 80 | MARK2 | 0.79489659 |
| 81 | GRK1 | 0.79165177 |
| 82 | TTN | 0.74171790 |
| 83 | PRKAA1 | 0.73651522 |
| 84 | SGK223 | 0.73150552 |
| 85 | SGK494 | 0.73150552 |
| 86 | RPS6KA2 | 0.73124983 |
| 87 | PTK2 | 0.71144997 |
| 88 | TAOK1 | 0.70437594 |
| 89 | KIT | 0.67856632 |
| 90 | MAP2K4 | 0.66894641 |
| 91 | TLK1 | 0.66700881 |
| 92 | CDK5 | 0.66658717 |
| 93 | MAP3K1 | 0.66082488 |
| 94 | NTRK1 | 0.65718229 |
| 95 | MAPK15 | 0.65177380 |
| 96 | PDK4 | 0.64543239 |
| 97 | PDK3 | 0.64543239 |
| 98 | MAP3K6 | 0.63602936 |
| 99 | NME2 | 0.62852159 |
| 100 | NEK9 | 0.62303801 |
| 101 | MUSK | 0.61474753 |
| 102 | MAPK4 | 0.58859301 |
| 103 | DYRK1A | 0.58600773 |
| 104 | ZAP70 | 0.58231030 |
| 105 | CSF1R | 0.57907808 |
| 106 | PINK1 | 0.57298419 |
| 107 | PRKCZ | 0.56919167 |
| 108 | UHMK1 | 0.55822793 |
| 109 | FES | 0.55296630 |
| 110 | PRKACG | 0.54045590 |
| 111 | PAK6 | 0.52754266 |
| 112 | BLK | 0.52585928 |
| 113 | MAP2K6 | 0.52496748 |
| 114 | PDPK1 | 0.52092950 |
| 115 | OXSR1 | 0.51862557 |
| 116 | ADRBK2 | 0.51685786 |
| 117 | GSK3A | 0.51029994 |
| 118 | SRC | 0.50379844 |
| 119 | TESK2 | 0.49465497 |
| 120 | MATK | 0.48904805 |
| 121 | JAK1 | 0.48680705 |
| 122 | FYN | 0.47776997 |
| 123 | STK39 | 0.47274391 |
| 124 | MTOR | 0.46092327 |
| 125 | CDC42BPA | 0.45932443 |
| 126 | PRKCG | 0.45775430 |
| 127 | MAP3K8 | 0.44648900 |
| 128 | TNK2 | 0.44466211 |
| 129 | ITK | 0.44395641 |
| 130 | PIM2 | 0.43587276 |
| 131 | LIMK1 | 0.43440190 |
| 132 | SIK3 | 0.43029797 |
| 133 | PRKCA | 0.42367997 |
| 134 | RPS6KB2 | 0.41973256 |
| 135 | MAPKAPK3 | 0.39417904 |
| 136 | CSK | 0.37014455 |
| 137 | CAMK2G | 0.36813688 |
| 138 | CDK6 | 0.36700306 |
| 139 | DAPK3 | 0.35964965 |
| 140 | MAPK12 | 0.35839097 |
| 141 | PDK2 | 0.32643761 |
| 142 | PAK3 | 0.31861185 |
| 143 | PDGFRA | 0.31243375 |
| 144 | BTK | 0.29483696 |
| 145 | DAPK2 | 0.29222377 |
| 146 | AKT2 | 0.28179828 |
| 147 | PDK1 | 0.28093211 |
| 148 | CAMK4 | 0.26821891 |
| 149 | TGFBR1 | 0.26252051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.66073786 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37943965 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93756775 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.83615435 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81317607 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65026107 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60858834 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58370293 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46478068 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35474584 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.22124516 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.17319739 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12900230 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12637191 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11933032 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.00916510 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97709471 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93890471 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91684321 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.90515668 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88154557 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87351668 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84343453 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75429258 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73281903 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72994904 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72807301 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.71521138 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.68446445 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66440441 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65970723 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59059476 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56012258 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52641169 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52404206 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50968199 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48621552 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45057700 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43822357 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43787713 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43497143 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37939299 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35863934 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32600086 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.32267005 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.30494315 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28787220 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24341354 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21786793 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19606004 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.14643590 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12706291 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08931875 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07658571 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07037695 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 1.03291612 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97120089 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96326151 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94449742 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93189493 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90990847 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89419786 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80027079 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.79434665 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76849558 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71332460 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66742369 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.60882053 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58449339 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50644054 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50090157 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45905049 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39114124 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37696126 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.35029655 |
| 76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33909503 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30378945 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29937930 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.29542343 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.28383271 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28282532 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26249742 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25918410 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23945746 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20240079 |
| 86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.19777865 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.19179727 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16302787 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.15855209 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13207796 |
| 91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.13145375 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.12585926 |
| 93 | Nicotine addiction_Homo sapiens_hsa05033 | 0.12430303 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.12213218 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12024167 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10684793 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09635978 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09239625 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.08997551 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08908425 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08367518 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.07630046 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07167820 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02090187 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1799268 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | -0.1703197 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1621049 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1572740 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1167355 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1055707 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | -0.0893523 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0733672 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0626015 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | -0.0396459 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0116553 |

